Credit Suisse's Sur...
Services: Diversified Services
Genetic Technologies Limited (GENE: NASDAQ)
$4.10 -0.09 | -2.15%
02/09/12 - 03:59 PM ET
101.02K / 36.40K
Vol / Avg. Vol:4.26 / 4.19
Open / Prev. Close:3.91 - 4.27
Today's Range:1.50 - 10.75
52 Wk Range:38.28%
Performance YTD:TheStreet Rating:
Portfolios with GENE
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- User- - -
- Contributor14 Penny Stocks Get Delisti...
- UserExperimental Equities
- UserMBW
- Userann's prorfolio
- UserPierco Long Term Growth Fund
- Usercalmocean Portfolio 1
- Userjohn99 Portfolio 1
Latest GENE Headlines from TheStreet
- 8 Stocks Under $10 Ripping Higher 01.26.12 | 02:01 pm
- Optimer Soars on Antibiotic Data 11.11.08 | 12:11 pm
- Biotech Buzz: Big Strides in Alzheimer's Drugs
01.10.08 | 05:01 pm - Funny Money 12.10.07 | 01:12 pm
- Ties May Bind Apple's CEO to Board 09.06.06 | 04:09 pm
- Wednesday's Small-Cap Winners & Losers 08.30.06 | 02:08 pm
- Sector Watch: Biotechs Pull Back Following Recent Surge 05.23.01 | 03:05 pm
Press Releases for GENE
- Break-Through Invention For Treating Cancer - Business Wire 11.07.11 | 10:11 am
- Genetic Technologies Limited Announces Quarterly Activities Report For The Quarter Ended 30 September 2011 - Business Wire 10.26.11 | 11:10 am
- Genetic Technologies’ BREVAGen™ Changing The Way US Physicians Assess Breast Cancer Risk - Business Wire 10.18.11 | 09:10 am
- Genetic Technologies Limited Appoints Dr. Mervyn Cass As Company Director - Business Wire 10.03.11 | 10:10 am
Partner Headlines for GENE
- Afternoon Market Top Percentage Gainers and Losers (CAAS, GENE, HNSN, SYMX, TPX, SCOK, QXM, IDIX, AIB, HERO) - Benzinga 04.08.11 | 01:04 pm
